Stay updated on TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial
Sign up to get notified when there's something new on the TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial page.

Latest updates to the TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe study record now displays a 403 Forbidden error page with a Home link, indicating access is blocked and the content is not loading as before. The page also shows the site revision note 'Revision: v3.7.0'.SummaryDifference19%

- Check36 days agoChange DetectedHealx AI was removed and Ovid Therapeutics Inc. was added as collaborators for the TAK-935 study, updating the organizations listed as collaborators on the trial page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, reflecting a minor metadata update to the page rather than changes to its main content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This appears to be a metadata update rather than a change to study information.SummaryDifference0.0%

Stay in the know with updates to TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-935 Adjunctive Therapy in Encephalopathies Clinical Trial page.